Finally, we evaluated the therapeutic value of the NAT10 specific inhibitor-remodelin in 4NQO-induced murine OSCC tumors through tumorigenesis and found that remodelin could inhibit tumor progression. The gene discussed is NAT10; the disease is neoplasm.